Funding for this research was provided by:
KI-Forskar-AT [to S.E.S]
KI-Clinical Scientist Training Programme [to S.E.S]
Region Stockholm [clinical research appointment to G.E.]
Swedish Research Council [to G.E] (2017-01954)
Svenska Läkaresällskapet [to K.M] (SLS-887241)
Swedish Foundation for Strategic Research [to A.R-D] (SB12-00347)
Swedish Research Council [to A.R-D] (2016-00748)
Getinge AB [to A.R-D] (4-1599/2018)
AIMES – Center for the Advancement of Integrated Medical and Engineering Sciences (www.aimes.se) at Karolinska Institutet (1-249/2019)
KTH Royal Institute of Technology (VF-2019-0110)
Region Stockholm (ALF project) [to A.B] (FOUI 995080)
the Foundation Olle Engkvist Byggmästare [to A.B] (186 678)
Karolinska Institutet funding [to A.B] (FS -2020:0007)
Received: 2 February 2022
Accepted: 16 May 2022
First Online: 31 May 2022
: The study was performed in accordance with the Declaration of Helsinki and was approved by the regional ethics committee in Stockholm (<i>Regionala etikprövningsnämnden i Stockholm</i>, dnr 2017/1743-31/1 and 2018/52-32). The requirement for informed consent was waived by the same committee (<i>Regionala etikprövningsnämnden i Stockholm</i>).
: Not applicable.
: There are no competing interest reported by any of the authors.